October 2025: People who have type 2 diabetes and take a semaglutide like Wegovy may have a significantly higher chance of experiencing blindness and other vision problems than others, a study has found
The ChEMBL drug registry records tirzepatide at maximum phase 4 (approved), first approval 2022, parenteral, with a first-in-class GIP-agonist designation and a boxed-warning flag
Vitamin C delivers a range of benefits to your skin by protecting it from sun damage , improve immune system and boosting collagen production.
J Clin Pharm Ther 37:510524 Painter NA, Morello CM, Singh RF, McBane SE (2013) An evidence-based and practical approach to using Bydureon in patients with type 2 diabetes
Hims & Hers: A broad consumer-health telehealth brand offering streamlined GLP-1 access with a smooth experience and lighter coaching
Each small line represents 2 units